ArticleRadiology. Imaging cancer2026
Deep Learning Model Based on Tumor and Visceral Adipose Tissue CT Features for Predicting Peritoneal Metastasis Risk after Radical Gastrectomy in Serosa-Invasive Gastric Cancer.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To develop and validate a deep learning model integrating tumor and visceral adipose tissue (VAT) CT scan features with clinical indicators to predict postoperative peritoneal metastasis in serosa-invasive gastric cancer. Materials and Methods This multicenter, retrospective study between April 2008 and January 2018 included patients with pathologically confirmed serosa-invasive gastric cancer. Patients were divided into training, internal test, and independent external test sets. Tumor and VAT regions were segmented at preoperative CT. Deep features were extracted using a ResNet18 network. A fused tumor-VAT deep learning signature (F-DLS) was generated, incorporating clinical variables into a multimodal deep learning radiomics model (MDLR) using a sparse Bayesian extreme learning machine. Model performance was assessed using receiver operating characteristic curve, integrated discrimination improvement, calibration, decision curve analysis, and recurrence-free survival. Results Among 416 patients (mean age, 56.6 years ± 11.6; 66.1% male patients), the F-DLS achieved area under the receiver operating characteristic curve (AUC) values of 0.81 (95% CI: 0.73, 0.88) in the internal test set and 0.79 (95% CI: 0.71, 0.86) in the external test set. Compared with the tumor tissue DLS and VAT-DLS, the F-DLS showed numerically higher AUCs without statistical significance. The MDLR achieved the strongest predictive performance, with AUCs of 0.86 (95% CI: 0.79, 0.92) in the internal test set and 0.86 (95% CI: 0.78, 0.92) in the external test set. The MDLR statistically significantly outperformed clinical and deep learning-only models (integrated discrimination improvement,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.